Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform.
about
Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer.Protein Regulator of Cytokinesis PRC1 Confers Chemoresistance and Predicts an Unfavorable Postoperative Survival of Hepatocellular Carcinoma Patients.Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance.Applications of label-free, quantitative phase holographic imaging cytometry to the development of multi-specific nanoscale pharmaceutical formulations.Biodegradable Polymersomes as Nanocarriers for Doxorubicin Hydrochloride: Enhanced Cytotoxicity in MCF-7/ADR Cells and Prolonged Blood Circulation.High accuracy label-free classification of single-cell kinetic states from holographic cytometry of human melanoma cells.Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review.Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway.Characterization of dormant and active human cancer cells by quantitative phase imaging.
P2860
Q37620476-97460B22-4087-42D1-B65C-5089C1B88900Q37738084-3F9E6FA5-866B-42AE-ACAD-594EDAF536CCQ38683263-AAF79945-3BB9-4171-87E9-791702C33568Q38858872-D4499155-35C8-4585-A1EE-A8665B84675FQ39076083-BC7C2302-8493-4A59-ACF6-88A1A63329D2Q41697058-4C2A7A91-821F-4B4D-9849-5196C7AEBF36Q45070718-6491A2BF-B8DA-449F-BB85-E28381EA0D63Q48522177-6AB4494B-BABD-422D-B8E1-D40F898A6C20Q48681495-49673A64-8111-42BE-A608-BD128C0B07D1
P2860
Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Reversal of Chemoresistance in ...... taxel in a Liposomal Platform.
@ast
Reversal of Chemoresistance in ...... taxel in a Liposomal Platform.
@en
type
label
Reversal of Chemoresistance in ...... taxel in a Liposomal Platform.
@ast
Reversal of Chemoresistance in ...... taxel in a Liposomal Platform.
@en
prefLabel
Reversal of Chemoresistance in ...... taxel in a Liposomal Platform.
@ast
Reversal of Chemoresistance in ...... taxel in a Liposomal Platform.
@en
P2093
P2860
P1476
Reversal of Chemoresistance in ...... taxel in a Liposomal Platform.
@en
P2093
Hilary A Kenny
Shravan Kumar Sriraman
Vladimir Torchilin
Yilin Zhang
P2860
P304
P356
10.1158/1535-7163.MCT-15-0986
P577
2016-07-27T00:00:00Z